John Marioni: Revolutionizing Drug Discovery Through Data and AI

John Marioni, senior vice president at Genentech, discusses the transformative impact of AI on drug discovery during a McKinsey podcast. With a background in academia, Marioni emphasizes the importance of interdisciplinary collaboration and the innovative use of AI and machine learning in biopharma. Genentech employs a “lab-in-the-loop” strategy to leverage AI models for predicting drug development outcomes, ultimately accelerating patient access to effective therapies. Marioni highlights the necessity of high-quality, well-organized data as foundational for AI models and stresses overcoming challenges related to data accessibility and integration. He acknowledges the skepticism that can arise from scientists accustomed to traditional methods but believes that demonstrating tangible benefits can foster acceptance of new technologies. Looking ahead, Marioni anticipates a future where AI tools become democratized and robotics play a significant role in laboratory processes, possibly transforming the biopharma landscape further.

Source link